Pharma Intelligence

This optimism follows a downturn in private biotech venture financing, where funding in 2023 declined by 43.2 per cent and 52.3…

The Korean Ministry of Food and Drug Safety (MFDS) has recently mandated the reporting of any suspected adverse reactions,…

HTIT has recently submitted a marketing authorisation application in China for first oral insulin for type 2 diabetes

According to GlobalData’s Pharma Intelligence Center Deals Database, SVB Financial Group and its subsidiaries were involved in…

There are currently 16 COVID-19 drugs in clinical development in China, five of which are in Phase III. Most of these drugs in the…

Karunya Sampath, co-founder and CEO, Payoda Technologies, explains how advanced analytics can be of help for the pharma sector 

Poornachandra Tejasvi K, Senior Director - Emerging Markets, India, Pharma Intelligence, talks about shifts and trends in…

ZyCoV-D’s Phase III interim analysis has shown efficacy of 66.6 per cent and was conducted in over 28,000 subjects, including 1000…

The highlights of the latest reforms are the drug patent linkage system, introduction of patent term extension for drugs and the…

On March 2, 2021, Cipla Gulf and Alvotech expanded their partnership to market and distribute four biosimilars; aflibercept…